Mechanisms of IL-18 activation appear to involve mitophagy blockade and ROS release, highlighting mitophagy and ROS as additional novel potential therapeutic targets for COVID-19-associated cardiopulmonary manifestations. This evidence concerns the gene IL18 and COVID-19.